A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism. - Suppr | 超能文献

A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism.

作者信息

Ogueh O, Johnson M R, Benjamin A

机构信息

Department of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital , 687 Pine Avenue West, Montreal , Canada H3A 1A1.

Academic Obstetrics and Gynaecology, Imperial College School of Medicine, Chelsea and Westminster Hospital , 369 Fulham Road, London SW10 9NH , UK.

出版信息

Obstet Med. 2009 Dec;2(4):157-60. doi: 10.1258/om.2009.090047. Epub 2009 Nov 30.

DOI:10.1258/om.2009.090047

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4989670/

Abstract

The aim of this study was to determine the effect of heparin thromboprophylaxis during pregnancy on maternal biochemical markers of bone metabolism. This was a prospective longitudinal study of carboxy terminal pro-peptide of type I collagen (PICP) and cross-linked carboxyterminal telopeptide of type I collagen (ICTP) levels in 15 women, who had heparin thromboprophylaxis during pregnancy compared with those of 18 normal pregnant controls. During pregnancy, the rate of change of PICP and ICTP in women who had heparin thromboprophylaxis was similar to those of women who did not (P = 0.184 for PICP, and P = 0.129 for ICTP), and PICP and ICTP levels at individual time points were similar in both groups. Therefore, heparin thromboprophylaxis during pregnancy does not affect maternal biochemical markers of bone metabolism.

摘要

相似文献

1

A longitudinal study of the effect of heparin thromboprophylaxis during pregnancy on maternal bone metabolism.

Obstet Med. 2009 Dec;2(4):157-60. doi: 10.1258/om.2009.090047. Epub 2009 Nov 30.

2

Maternal and fetal plasma levels of markers of bone metabolism in gestational diabetic pregnancies.

Early Hum Dev. 1998 Dec;53(2):155-61. doi: 10.1016/s0378-3782(98)00048-6.

3

Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.

World J Surg. 1996 Sep;20(7):753-6; discussion 756-7. doi: 10.1007/s002689900114.

4

[Serum concentration of pyridinoline cross-linked carboxy-terminal telopeptide of type-I collagen (ICTP) and carboxyterminal propeptide of human type I procollagen (PICP) in the diagnosis of bone metastases].

Kaku Igaku. 1996 Jan;33(1):77-84.

5

A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia.

BJOG. 2002 Jun;109(6):708-13. doi: 10.1111/j.1471-0528.2002.00353.x.

6

[Studies of type I collagen related substances as bone metastatic markers of prostate carcinoma with special regard to serum carboxyterminal propeptide of type. I. Procollagen (PICP), cross-linked carboxyterminal telopeptide of type I collagen (ICTP) and Urinary deoxypyridinoline levels].

Nihon Hinyokika Gakkai Zasshi. 1998 Apr;89(4):484-91. doi: 10.5980/jpnjurol1989.89.484.

7

Clinical usefulness of serum carboxyterminal propeptide of type I procollagen and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer.

Jpn J Clin Oncol. 1996 Jun;26(3):157-63. doi: 10.1093/oxfordjournals.jjco.a023200.

8

Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.

Anticancer Res. 1996 Jul-Aug;16(4B):2289-93.

9

Assessment of biochemical markers of bone metabolism in relation to the occurrence of fracture: a retrospective and prospective population-based study of women.

J Bone Miner Res. 1995 Nov;10(11):1823-9. doi: 10.1002/jbmr.5650101127.

10

Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.

Anticancer Res. 2004 Sep-Oct;24(5B):3193-201.

本文引用的文献

1

Biochemical markers of bone turnover during pregnancy: a longitudinal study.

Exp Clin Endocrinol Diabetes. 2006 Oct;114(9):506-10. doi: 10.1055/s-2006-951627.

2

Bone density changes in women who receive thromboprophylaxis in pregnancy.

Am J Obstet Gynecol. 2006 Oct;195(4):1109-13. doi: 10.1016/j.ajog.2006.06.080.

3

Minimising the risk of heparin-induced osteoporosis during pregnancy.

Expert Opin Drug Saf. 2005 May;4(3):583-90. doi: 10.1517/14740338.4.3.583.

4

Prospective observational study of bone mineral density during pregnancy: low molecular weight heparin versus control.

Hum Reprod. 2004 May;19(5):1211-4. doi: 10.1093/humrep/deh115. Epub 2004 Apr 7.

5

Bone remodeling and bone mineral density during pregnancy.

Arch Gynecol Obstet. 2003 Oct;268(4):309-16. doi: 10.1007/s00404-002-0410-8. Epub 2003 Jan 8.

6

Changes in serum markers of bone turnover during normal pregnancy.

Ann Clin Biochem. 2003 Sep;40(Pt 5):508-13. doi: 10.1258/000456303322326416.

7

Short-term low-dose heparin plus bedrest impairs bone metabolism in pregnant women.

Eur J Obstet Gynecol Reprod Biol. 2003 Jan 10;106(1):25-30. doi: 10.1016/s0301-2115(02)00200-2.

8

A longitudinal study of biochemical markers of bone turnover during normal pregnancy and pregnancies complicated by pre-eclampsia.

BJOG. 2002 Jun;109(6):708-13. doi: 10.1111/j.1471-0528.2002.00353.x.

9

Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.

Thromb Haemost. 2002 Feb;87(2):182-6.

10

Outcome of pregnancy in women with hereditary thrombophilia.

Int J Gynaecol Obstet. 2001 Sep;74(3):247-53. doi: 10.1016/s0020-7292(01)00447-7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。